{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:23:29Z","timestamp":1784175809613,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["82200220"],"award-info":[{"award-number":["82200220"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["24NSFSC3229"],"award-info":[{"award-number":["24NSFSC3229"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470196"],"award-info":[{"award-number":["82470196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070219"],"award-info":[{"award-number":["82070219"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"publisher","award":["2024YFFK0321"],"award-info":[{"award-number":["2024YFFK0321"]}],"id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bcp.2025.116948","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:35:18Z","timestamp":1744479318000},"page":"116948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["LncRNA HCG11 regulates selinexor sensitivity in multiple myeloma"],"prefix":"10.1016","volume":"237","author":[{"given":"Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5855-4343","authenticated-orcid":false,"given":"Yuhuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bcp.2025.116948_b0005","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.6004\/jnccn.2023.0061","article-title":"Multiple myeloma, version 2.2024, NCCN clinical practice guidelines in oncology","volume":"21","author":"Kumar","year":"2023","journal-title":"J. Natl. Compreh. Cancer Netwk. JNCCN"},{"issue":"1","key":"10.1016\/j.bcp.2025.116948_b0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13045-020-00980-5","article-title":"Emerging agents and regimens for multiple myeloma","volume":"13","author":"Yang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2025.116948_b0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41571-020-00442-4","article-title":"The nuclear export protein XPO1 - from biology to targeted therapy","volume":"18","author":"Azmi","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.bcp.2025.116948_b0020","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s40265-019-01188-9","article-title":"Selinexor: first global approval","volume":"79","author":"Syed","year":"2019","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.bcp.2025.116948_b0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa1903455","article-title":"Oral selinexor-dexamethasone for triple-class refractory multiple myeloma","volume":"381","author":"Chari","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.116948_b0030","doi-asserted-by":"crossref","unstructured":"XPO1 Inhibitor Approved for Multiple Myeloma. Cancer discovery. 2019;9(9):1150-1.","DOI":"10.1158\/2159-8290.CD-NB2019-085"},{"issue":"12","key":"10.1016\/j.bcp.2025.116948_b0035","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00277-022-04999-1","article-title":"Efficacy and safety of selinexor-based regimens for relapsed\/refractory multiple myeloma: a systematic review of literature","volume":"101","author":"Masood","year":"2022","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116948_b0040","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202009045","article-title":"LNCcation: lncRNA localization and function","volume":"220","author":"Bridges","year":"2021","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.116948_b0045","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4161\/rna.24604","article-title":"On the classification of long non-coding RNAs","volume":"10","author":"Ma","year":"2013","journal-title":"RNA Biol."},{"issue":"3","key":"10.1016\/j.bcp.2025.116948_b0050","doi-asserted-by":"crossref","first-page":"C684","DOI":"10.1152\/ajpcell.00348.2023","article-title":"ALKHB5-demethylated lncRNA SNHG15 promotes myeloma tumorigenicity by increasing chromatin accessibility and recruiting H3K36me3 modifier SETD2","volume":"326","author":"Yao","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116948_b0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.yexcr.2018.06.026","article-title":"LncRNA PRAL is closely related to clinical prognosis of multiple myeloma and the bortezomib sensitivity","volume":"370","author":"Xiao","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2025.116948_b0060","article-title":"The role and mechanism of HLA complex group 11 in cancer","volume":"143","author":"Yuan","year":"2021","journal-title":"Biomed. Pharmacother. = Biomedecine & Pharmacotherapie."},{"key":"10.1016\/j.bcp.2025.116948_b0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12935-019-1046-0","article-title":"LncRNA HCG11 promotes proliferation and migration in gastric cancer via targeting miR-1276\/CTNNB1 and activating Wnt signaling pathway","volume":"19","author":"Zhang","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.bcp.2025.116948_b0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cyto.b.21961","article-title":"CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab","volume":"100","author":"Soh","year":"2021","journal-title":"Cytometry B Clin. Cytom."},{"issue":"23","key":"10.1016\/j.bcp.2025.116948_b0075","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1182\/bloodadvances.2021004695","article-title":"ALCAM-EGFR interaction regulates myelomagenesis","volume":"5","author":"Luo","year":"2021","journal-title":"Blood Adv."},{"issue":"11","key":"10.1016\/j.bcp.2025.116948_b0080","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw131","article-title":"Role of myeloma-derived mif in myeloma cell adhesion to bone marrow and chemotherapy response","volume":"108","author":"Zheng","year":"2016","journal-title":"J. Natl Cancer Inst."},{"issue":"2","key":"10.1016\/j.bcp.2025.116948_b0085","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/bjh.19468","article-title":"Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide","volume":"205","author":"Lin","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcp.2025.116948_b0090","article-title":"Polysome fractionation and analysis of mammalian translatomes on a genome-wide scale","volume":"87","author":"Gandin","year":"2014","journal-title":"J. Visual. Experiment. JOVE"},{"key":"10.1016\/j.bcp.2025.116948_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216486","article-title":"RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexor","volume":"580","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bcp.2025.116948_b0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41598-017-00252-2","article-title":"Seven LncRNA-mRNA based risk score predicts the survival of head and neck squamous cell carcinoma","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.bcp.2025.116948_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114285","article-title":"A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy","volume":"189","author":"Sun","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2025.116948_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2021.11.011","article-title":"NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis","volume":"33","author":"Park","year":"2021","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bcp.2025.116948_b0115","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20182372","article-title":"LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression","volume":"39","author":"Zhou","year":"2019","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2025.116948_b0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cac2.12108","article-title":"LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer","volume":"41","author":"Tan","year":"2021","journal-title":"Cancer Commun. (London, England)."},{"issue":"4","key":"10.1016\/j.bcp.2025.116948_b0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.2022016892","article-title":"A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth","volume":"141","author":"Morelli","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2025.116948_b0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/leu.2013.115","article-title":"CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications","volume":"28","author":"Tai","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bcp.2025.116948_b0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jha2.120","article-title":"Overall survival with oral selinexor plus low-dose dexamethasone versus real-world therapy in triple-class-refractory multiple myeloma","volume":"2","author":"Richardson","year":"2021","journal-title":"EJHaem."},{"key":"10.1016\/j.bcp.2025.116948_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108722","article-title":"Drug resistance biomarker ABCC4 of selinexor and immune feature in multiple myeloma","volume":"108","author":"Hu","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2025.116948_b0145","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1182\/bloodadvances.2021006638","article-title":"Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects","volume":"7","author":"Li","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcp.2025.116948_b0150","article-title":"A three-gene signature predicts response to selinexor in multiple myeloma","volume":"6","author":"Restrepo","year":"2022","journal-title":"JCO Precis. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2025.116948_b0155","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3892\/ijo.2017.4066","article-title":"Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction","volume":"51","author":"Xu","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2025.116948_b0160","doi-asserted-by":"crossref","first-page":"e3074","DOI":"10.1002\/jgm.3074","article-title":"Long non-coding RNA HCG11 suppresses the growth of glioma by cooperating with the miR-4425\/MTA3 axis","volume":"21","author":"Zhang","year":"2019","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bcp.2025.116948_b0165","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9011232","article-title":"lncRNA HCG11 promotes colorectal cancer cell malignant behaviors via sponging miR-26b-5p","volume":"2023","author":"Guo","year":"2023","journal-title":"J. Immunol. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225002102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225002102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:22:23Z","timestamp":1762096943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225002102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":33,"alternative-id":["S0006295225002102"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116948","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LncRNA HCG11 regulates selinexor sensitivity in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116948","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116948"}}